Canadian Urological Association guideline: Management of small renal masses - Full-text

Patrick O Richard¹, Philippe D Violette², Bimal Bhindi³, Rodney H Breau⁴, Wassim Kassouf⁵, Luke T Lavallée⁴, Michael Jewett⁶, John R Kachura⁷, Anil Kapoor⁸, Maxine Noel-Lamy⁹, Michael Ordon¹⁰, Stephen E Pautler¹¹, Frédéric Pouliot¹², Alan I So¹³, Ricardo A Rendon¹⁴, Simon Tanguay⁵, Christine Collins¹⁵, Maryam Kandi², Bobby Shayegan⁸, Andrew Weller¹⁵, Antonio Finelli⁶, Andrea Kokorovic¹⁶, Jay Nayak¹⁷

Affiliations

¹ Department of Surgery, Division of Urology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
² Departments of Health Research Methods Evidence and Impact (HEI) and Surgery, McMaster University, Hamilton, ON, Canada.
³ Southern Alberta Institute of Urology, University of Calgary, Calgary, AB, Canada.
⁴ Department of Surgery, Division of Urology, University of Ottawa, Ottawa, ON, Canada.
⁵ Department of Surgery, Division of Urology, McGill University Health Centre, Montreal, QC, Canada.
⁶ Department of Surgical Oncology, Division of Urology, Princess Margaret Hospital, Toronto, ON, Canada.
⁷ Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
⁸ McMaster Institute of Urology, St. Joseph Healthcare, Hamilton, ON, Canada.
⁹ Department of Medical Imaging, Division of Interventional Radiology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
¹⁰ Department of Surgery, Division of Urology, St. Michael's Hospital, Toronto, ON, Canada.
¹¹ Department of Surgery, Division of Urology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
¹² Department of Surgery, Division of Urology, Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada.
¹³ Division of Urology, British Columbia Cancer Care, Vancouver, BC, Canada.
¹⁴ Department of Surgery, Division of Urology, Capital Health - QEII, Halifax, NS, Canada.
¹⁵ Kidney Cancer Canada, Mississauga, ON, Canada.
¹⁶ Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
¹⁷ Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

PMID: 35133268
PMCID: PMC8932428
DOI: 10.5489/cuaj.7763

Canadian Urological Association guideline: Management of small renal masses - Full-text

Patrick O Richard et al. Can Urol Assoc J. 2022 Feb.

. 2022 Feb;16(2):E61-E75.

doi: 10.5489/cuaj.7763.

Authors

Affiliations

¹ Department of Surgery, Division of Urology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
² Departments of Health Research Methods Evidence and Impact (HEI) and Surgery, McMaster University, Hamilton, ON, Canada.
³ Southern Alberta Institute of Urology, University of Calgary, Calgary, AB, Canada.
⁴ Department of Surgery, Division of Urology, University of Ottawa, Ottawa, ON, Canada.
⁵ Department of Surgery, Division of Urology, McGill University Health Centre, Montreal, QC, Canada.
⁶ Department of Surgical Oncology, Division of Urology, Princess Margaret Hospital, Toronto, ON, Canada.
⁷ Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
⁸ McMaster Institute of Urology, St. Joseph Healthcare, Hamilton, ON, Canada.
⁹ Department of Medical Imaging, Division of Interventional Radiology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
¹⁰ Department of Surgery, Division of Urology, St. Michael's Hospital, Toronto, ON, Canada.
¹¹ Department of Surgery, Division of Urology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
¹² Department of Surgery, Division of Urology, Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada.
¹³ Division of Urology, British Columbia Cancer Care, Vancouver, BC, Canada.
¹⁴ Department of Surgery, Division of Urology, Capital Health - QEII, Halifax, NS, Canada.
¹⁵ Kidney Cancer Canada, Mississauga, ON, Canada.
¹⁶ Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
¹⁷ Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

PMID: 35133268
PMCID: PMC8932428
DOI: 10.5489/cuaj.7763

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Richard has been an advisory board member for Bayer, Janssen, and Sanofi; and a speakers’ bureau member for Abbvie, Amgen, Astellas, Ferring, and Janssen. Dr. Bhindi has been an advisory board member for Bayer and Janssen; and has received speaker honoraria from Merck. Dr. Breau has been an advisory board member for Ferring (bladder cancer). Dr. Kassouf has been an advisory board member for EMD Serono and Pfizer; has received grants and/or honoraria from Abbvie, Astellas, BMS, Ferring, Janssen, Merck, Roche, and Sesen Bio; and has participated in clinical trials supported by Astra Zeneca, BMS, Janssen, Pfizer, Roche, Sesen Bio, and Theralase. Dr. Lavallée has participated in advisory boards for Abbvie, Bayer, Ferring, Sanofi, and Tersera; and has received an unrestricted research grant from Sanofi. Dr. Jewett has been an advisory board member for and received payment from Sesen Bio and Theralase Technologies Ltd. Dr. Kachura participated in the multicenter OPTIMA trial for liver cancer ablation supported by Celsion Inc. Dr. Pouliot has been an advisory board member for Astellas, Bayer, Esai, Janssen, Merck, Sanofi, and Tersera; holds investments in Allogene Therapeutics; and has participated in clinical trials supported by Lantheus, Merck, and Progenics. Dr. So has been an advisory board member for Abbvie, Amgen, Bayer, Ferring, Janssen, Merck, and Tersera. Dr. Rendon has been an advisory board and speakers’ bureau member for and has received honoraria from AbbVie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Jansen, and Sanofi. Dr. Tanguay has participated in advisory boards for BMS, Janssen, Knight Therapeutics, Merck, and Roche; and has participated in clinical trials supported by AstraZeneca and Roche. Dr. Shayegan has been an advisory board member for Astellas, Bayer, and Janssen; and has received a research grant from Janssen. The remaining authors do not report any competing personal or financial interests related to this work.

Figures

**Fig. 1**
Algorithm for the management of small renal masses. CT: computed tomography; CXR: chest X-ray; eGFR: estimated glomerular filtration rate; KCNRC: Kidney Research Network of Canada; MRI: magnetic resonance imaging.

See this image and copyright information in PMC

References

1. Welch H, Skinner J, Schroeck F, et al. Regional variation of computed tomographic imaging in the United States and the risk of nephrectomy. JAMA Intern Med. 2018;178:221–7. doi: 10.1001/jamainternmed.2017.7508. - DOI - PMC - PubMed
1. Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74–84. doi: 10.1016/j.eururo.2018.08.036. - DOI - PMC - PubMed
1. Bhindi B, Thompson R, Lohse C, et al. The probability of aggressive vs. indolent histology based on renal tumor Size: Implications for surveillance and treatment. Eur Urol. 2018;74:489–97. doi: 10.1016/j.eururo.2018.06.003. - DOI - PubMed
1. Richard P, Lavallée L, Pouliot F, et al. Is routine renal tumor biopsy associated with lower rates of benign histology following nephrectomy for small renal masses? J Urol. 2018;200:731–6. doi: 10.1016/j.juro.2018.04.015. - DOI - PubMed
1. Richard PO, Jewett MA, Bhatt JR, et al. Renal tumor biopsy for small renal masses: A single-center, 13-year experience. Eur Urol. 2015;68:1007–13. doi: 10.1016/j.eururo.2015.04.004. - DOI - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Canadian Urological Association guideline: Management of small renal masses - Full-text

Affiliations

Canadian Urological Association guideline: Management of small renal masses - Full-text

Authors

Affiliations

Conflict of interest statement

Figures

References

LinkOut - more resources

Full Text Sources